Global Hemostatic Gel Market Growth 2023-2029

Global Hemostatic Gel Market Growth 2023-2029

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.
LPI (LP Information)' newest research report, the “Hemostatic Gel Industry Forecast” looks at past sales and reviews total world Hemostatic Gel sales in 2022, providing a comprehensive analysis by region and market sector of projected Hemostatic Gel sales for 2023 through 2029. With Hemostatic Gel sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostatic Gel industry.
This Insight Report provides a comprehensive analysis of the global Hemostatic Gel landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostatic Gel portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hemostatic Gel market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostatic Gel and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostatic Gel.
The global Hemostatic Gel market size is projected to grow from US$ 926.7 million in 2022 to US$ 1338.6 million in 2029; it is expected to grow at a CAGR of 1338.6 from 2023 to 2029.
Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.
In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostatic Gel market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Fibrin
Gelatin
Other
Segmentation by application
Minimally Invasive Surgery
General Surgery
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Baxter
J&J
CryoLife
Integra Life Sciences
Advance Medical Solution
BD
CSL Behring
Pfizer
B Braun
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hemostatic Gel market?
What factors are driving Hemostatic Gel market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemostatic Gel market opportunities vary by end market size?
How does Hemostatic Gel break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.